Research projects

Beating treatment resistance in childhood brain cancers

Professor Adrian Bracken
Project period
Mar 2018 - Mar 2021
Research Institute
Trinity College Dublin
Cancer types
Brain cancer
Professor Adrian Bracken

Aim of the research

Professor Adrian Bracken is using funding from Worldwide Cancer Research and The Brain Tumour Charity to look for ways to bypass resistance to a treatment for a rare but aggressive childhood brain cancer called paediatric diffuse intrinsic pontine gliomas (DIPG).

Meet the scientist

Dr. Adrian Bracken is an Associate Professor at The Smurfit Institute of Genetics, Trinity College Dublin. His lab are looking into the changes in our cells that can switch genes "on or off" and their implications for cancer.

More about the research project

Targeted cancer treatments can be very effective, but they don't work the same for everyone because some patient's tumours will inevitably develop resistance to the treatment, or be resistant already.

Proteins in cells that regulate the on/off state of genes have been implicated in a variety of cancers and recent breakthroughs have identified once such protein, called EZH2, as a promising target for treating DIPG.

It's inevitable that some tumours will be resistant to drugs that block EZH2, so Professor Bracken is looking for ways to indirectly block it by targeting other associated proteins. Research has shown that EZH2 works in concert with several other proteins - so his team wants to find out if they can inhibit these to produce the same cancer-stopping effect.


This project was made possible thanks to a co-funding partnership with The Brain Tumour Charity.